Early research suggesting that a popular non-psychoactive compound derived from marijuana might help prevent or treat Covid-19 warrants further investigation in rigorous clinical trials, researchers say.

Several recent laboratory studies of cannabidiol, or CBD, have shown promising results, attracting media attention.

However, many other potential Covid treatments that showed promise in test tubes, from hydroxychloroquine to...